Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2012
09/20/2012WO2012124513A1 Modified d-succinylase having improved d-form selectivity for n-succinyl-dl-amino acid
09/20/2012WO2012124338A1 Probe for analyzing biological tissue and method for utilizing same
09/20/2012WO2012124334A1 Antibody, pharmaceutical composition used for treatment of breast cancer, tumor test method, and reagent for testing tumor
09/20/2012WO2012123613A1 Inhibitors of s1p receptors for the treatment of calcific aortic stenosis
09/20/2012WO2012123610A1 Transcriptional fusion vectors for uni and bidirectional promoter regions for use in lactic bacteria
09/20/2012WO2012123591A1 Method for targeting nucleic acids to the nucleus
09/20/2012WO2012123430A1 Capsid-free aav vectors, compositions, and methods for vector production and gene delivery
09/20/2012WO2012123429A1 Vector-host system
09/20/2012WO2012122985A1 Antagonists of the interleukin- 1 receptor
09/20/2012WO2012122943A1 Anti-hepatitis b virus x protein polypeptide drug
09/20/2012WO2012122942A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122941A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122765A1 Recombinant spore with bombyxmori alcohol dehydrogenase displayed on its surface and preparing method thereof
09/20/2012WO2012122732A1 Control/standard for nucleic acid detection of enveloped rna virus and applications thereof
09/20/2012WO2012122657A1 Nlrp7-based diagnosis of female reproductive conditions
09/20/2012WO2012122649A1 Recombinant orf virus
09/20/2012WO2012122645A1 Methods of treating cancer by inhibition of dna repair proteins
09/20/2012WO2012122640A1 Compositions, diagnostic methods using epithelial extracellular matrix proteins
09/20/2012WO2012122627A1 Magnetic particle scavenging device and method
09/20/2012WO2012122611A1 Method for the production of recombinant human factor viii
09/20/2012WO2012100083A3 Human induced neuronal cells
09/20/2012WO2012099447A3 Transgenic pig expressing stnfr1-fc genes and the use thereof
09/20/2012WO2012088247A3 Anti-c5/c5a/c5adesr antibodies and fragments
09/20/2012WO2012067466A3 Yarrowia lipolytica-derived peptide-n-glycosidase, and use thereof
09/20/2012WO2012067465A3 Automatic necleic acid purification apparatus and method for aerosol-protecting
09/20/2012WO2012064879A3 Arogenate dehydratases and lignification
09/20/2012WO2012061405A3 Differential detection and quantification of oxalobacter
09/20/2012WO2012058494A3 Isoprene synthase variants for improved production of isoprene
09/20/2012WO2012054919A3 Control of pathogens and parasites
09/20/2012WO2012050611A3 Aptamers to glycoprotein vi
09/20/2012WO2011135280A3 Enzymes
09/20/2012WO2011109031A8 Methods for cloning and manipulating genomes
09/20/2012US20120240293 Polypeptides having xylanase activity and polynucleotides encoding same
09/20/2012US20120240292 Proteins relating to grain shape and leaf shape of rice, coding genes and uses thereof
09/20/2012US20120240291 Regulatory regions preferentially expressing in non-pollen plant tissue
09/20/2012US20120240290 Methods and Compositions for Modulating Flowering and Maturity in Plants
09/20/2012US20120240289 Methods and means to alter lipid biosynthesis by targeting multiple enzymes to suborganelle domains
09/20/2012US20120240287 Expression Cassettes for Embryo-Specific Expression in Plants
09/20/2012US20120240286 Nucleic acid promoter sequences that control gene expression in plants
09/20/2012US20120240284 Cloning and exploitation of a functional r-gene from solanum chacoense
09/20/2012US20120240270 Novel snap pea variety sugar flash
09/20/2012US20120240269 Pea line dlsc7v0955
09/20/2012US20120240268 Pea line ex 08570956
09/20/2012US20120240267 Pea line ex 08570935
09/20/2012US20120240266 Soybean Variety XB30AL11
09/20/2012US20120240265 Soybean Variety XB32J11
09/20/2012US20120240264 Soybean Variety XB31E11
09/20/2012US20120240263 Soybean Variety XB25Y11
09/20/2012US20120240262 Soybean Variety XB32AR11
09/20/2012US20120240261 Soybean Variety XB26E11
09/20/2012US20120240260 Soybean Variety XB25Q11
09/20/2012US20120240259 Soybean Variety XB23K11
09/20/2012US20120240258 Soybean Variety XB22P11
09/20/2012US20120240257 Soybean Variety XB16R11
09/20/2012US20120240256 Soybean Variety XB14G11
09/20/2012US20120240255 Soybean Variety XB09C11
09/20/2012US20120240254 Soybean Variety XB09P11
09/20/2012US20120240253 Soybean Variety XB07Y11
09/20/2012US20120240252 Soybean Variety XB07A11
09/20/2012US20120240251 Soybean Variety XB06M11
09/20/2012US20120240250 Soybean Variety XB04Q11
09/20/2012US20120240248 Novel Fatty Acid Desaturase and Uses Thereof
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120240246 Variant Calpastatins and Variant Calpains for Modulating the Activity or Stability of Calpain
09/20/2012US20120238747 Transfection reagents
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120238727 Decorin compositions and use thereof
09/20/2012US20120238724 Mutated immunoglobulin-binding protein
09/20/2012US20120238620 TRYPTOPHANYL-tRNA SYNTHETASE-DERIVED POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
09/20/2012US20120238618 Pharmaceutical Composition Comprising Anti-miRNA Antisense Oligonucleotides
09/20/2012US20120238509 Urocortin 2 analogs and uses thereof
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238497 Glp-1 fusion peptides, their production and use
09/20/2012US20120238496 Fusion protein regulating plasma glucose and lipid, its preparation method and use
09/20/2012US20120238475 Methods of Amplifying and Sequencing Nucleic Acids
09/20/2012US20120238466 Multiplexed Assay Using Encoded Solid Support Matrices
09/20/2012US20120238039 Novel immobilizing fusion protein for effective and oriented immobilization of antibody on surfaces
09/20/2012US20120238024 Anti-Microbial Biotherapeutic Agents: Alternatives to Conventional Pharmaceutical Antibiotics
09/20/2012US20120238023 Novel Method for Producing Differentiated Cells
09/20/2012US20120238022 INDUCIBLE SYSTEMS AND METHODS FOR CONTROLLING siRNA EXPRESSION
09/20/2012US20120238017 Novel sirna structure for minimizing off-target effects and relaxing saturation of rnai machinery and the use thereof
09/20/2012US20120237993 Polypeptides Having Cellobiohydrolase 1 Activity and Polynucleotides Encoding Same
09/20/2012US20120237991 Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein
09/20/2012US20120237981 Amylases, nucleic acids encoding them and methods for making and using them
09/20/2012US20120237979 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
09/20/2012US20120237978 GPCR Fusion Protein Containing an N-Terminal Autonomously Folding Stable Domain, and Crystals of the Same
09/20/2012US20120237976 Mammalian expression vectors and uses thereof
09/20/2012US20120237975 Engineered nucleic acids and methods of use thereof
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237971 Methods, cells and systems for incorporating non-canonical amino acids into proteins
09/20/2012US20120237969 Method of Preparing Cells Susceptible to Transmissible Spongiform Encephalopathy and the Creation of TSE Persistently Infected Cells
09/20/2012US20120237966 Light Controlled Protein Dimerization in Cells
09/20/2012US20120237956 Treponema pallidum triplet antigen
09/20/2012US20120237935 Reagent kit for quantitatively detecting the mutations of epidermal growth factor receptor(egfr)
09/20/2012US20120237926 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
09/20/2012US20120237664 Generation of plants with altered protein, fiber, or oil content
09/20/2012US20120237614 Peptide able to disrupt the protein complex between the his273 mutaded p53 protein and the oncosuppressive p73 protein in tumor cells and therapeutic uses thereof
09/20/2012US20120237589 Amphoteric liposomes comprising imino lipids
09/20/2012US20120237538 RECOMBINANTLY EXPRESSED PLASMODIUM CelTOS ANTIGEN AND METHODS OF USE THEREOF
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis